Waksal Harlan 4
4 · Lyra Therapeutics, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
Waksal Harlan
DirectorExecutive Chair
Transactions
- Award
Common Stock
2024-03-18+275,000→ 536,966 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on January 31, 2025.